Tracking ENcapsulation of Pancreatic Collections in Acute Necrotizing Pancreatitis

Sponsor
Postgraduate Institute of Medical Education and Research, Chandigarh (Other)
Overall Status
Recruiting
CT.gov ID
NCT05716633
Collaborator
(none)
100
1
34.9
2.9

Study Details

Study Description

Brief Summary

The goal of this study is to investigate the encapsulation of fluid collections in patients with ANP using serial MRI.

The main questions it aims to answer are:
  • Evaluating the timing of encapsulation of necrotic fluid collection using serial non-enhanced MRI.

  • Identifying the factors that affect the timing of encapsulation of necrotic fluid collections Participants will undergo serial MRI scans (all with the same protocol) performed starting at day 15. Subsequent scans will be performed at 5 days interval till the clinically significant encapsulation (for all the collections in an individual patient) is seen or patients are excluded from the protocol due to intervention.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: MRI

Detailed Description

Consecutive patients with ANP presenting to the hospital within 2 weeks from the pain onset will be recruited. They will undergo serial non-contrast MRI starting at day 15 and every 5 days thereafter, till complete encapsulation of PFC. Ultrasound evaluation of the collection will be performed on the day of MRI by a radiologist not involved in evaluation of MRI. The site and volume of collection as well as thickness and completeness of the capsule and solid content within the collection will be recorded independently by two radiologists. The timing of clinically significant (>50% of PFC show capsule) and complete encapsulation will be recorded. The proportion of collections encapsulating in each week after 2nd week of illness will be recorded. The association between timing of encapsulation and clinical/biochemical parameters will be assessed. The correlation between the degree of encapsulation and percentage of solid components will also be documented. Multivariate analysis will be performed to identify factors associated with timing of encapsulation.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Tracking the ENcapsulation of Pancreatic Collections in Acute Necrotizing Pancreatitis. A Serial MRI Based Prospective Study (MRI-ENCAP Study)
Actual Study Start Date :
Feb 2, 2023
Anticipated Primary Completion Date :
Dec 31, 2025
Anticipated Study Completion Date :
Dec 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Acute Pancreatitis

Patients with acute pancreatitis will undergo serial MRI

Diagnostic Test: MRI
Serial MRI scans will be performed starting at day 15 from date of pain. Subsequent scans will be performed at 5 days interval till the clinically significant encapsulation (for all the collections in an individual patient) is seen.

Outcome Measures

Primary Outcome Measures

  1. Timing of Encapsulation [1-2 months after initial MRI]

    MRI scans will be performed

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Acute necrotizing pancreatitis

  2. Presentation to hospital within 2 weeks of pain onset

  3. Willing to give informed consent

Exclusion Criteria:
  1. Contraindications to non- enhanced MRI (Claustrophobia, cardiac pacemaker, cochlear implant).

  2. Acute on chronic pancreatitis

  3. Mechanical ventilation, ionotropic support (precluding safe environment in MRI).

  4. Drainage or aspiration of a collection prior to recruitment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Post Graduate Institute of Medical Education and Research Chandigarh Punjab India 160012

Sponsors and Collaborators

  • Postgraduate Institute of Medical Education and Research, Chandigarh

Investigators

  • Principal Investigator: Pankaj Gupta, PGIMER, CHANDIGARH

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Pankaj Gupta, Associate Professor, Postgraduate Institute of Medical Education and Research, Chandigarh
ClinicalTrials.gov Identifier:
NCT05716633
Other Study ID Numbers:
  • 32055
First Posted:
Feb 8, 2023
Last Update Posted:
Feb 8, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Pankaj Gupta, Associate Professor, Postgraduate Institute of Medical Education and Research, Chandigarh
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 8, 2023